Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study

NCT: NCT05744934 · COMPLETED

NCT IDNCT05744934
StatusCOMPLETED
Start Date2023-03-15
Completion2025-12-30

Brief Summary

The primary objective of this investigation is to evaluate the feasibility and safety of implantable loop recorder implantation (using the LUX-DX™) in newborns undergoing stage 1 palliation. The secondary objective of the investigation is to evaluate the feasibility of continuous measurement of heart rate and arrhythmia using an implantable loop recorder (LUX-Dx™) during the interstage period. An implantable loop recorder will be placed at the time of chest closure following stage 1 palliation (either at the time of index surgery or delayed). The device will be placed in a subclavicular pouch through the existing sternotomy incision. Participants will be in the study for 6 months to 3 years.

Frequently Asked Questions

What is Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study?

Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study is a clinical trial registered under NCT05744934. Current status: COMPLETED.

What is the status of NCT05744934?

The current status of NCT05744934 (Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study) is: COMPLETED.

When did Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study start?

Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study started on 2023-03-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.